COMED Therapeutics

COMED Therapeutics is a cutting-edge biotechnology company focused on developing innovative intracellular therapies. With a commitment to redefining precision medicine, COMED Therapeutics is dedicated to creating solutions that target and treat diseases at their source. Located at the Malta Life Sciences Park, LS2 Building Level 0 Unit 7, San Gwann, SGN3000, MT, COMED Therapeutics is advancing a portfolio of therapeutic candidates through preclinical research, with a lead program targeting pancreatic cancer.

COMED Therapeutics' patented platform enables the delivery of therapeutic molecules directly into cells, unlocking disease targets previously considered inaccessible. By combining this innovative delivery system with a range of engineered antibodies, COMED Therapeutics is creating new opportunities to overcome the limitations of conventional biologics and address diseases driven by intracellular mechanisms. The company’s focus extends to spinal muscular atrophy (SMA) and malaria, reflecting its dedication to tackling some of the world’s most challenging health burdens.

COMED Therapeutics operates from a state-of-the-art laboratory, supported by strategic European partnerships and a team of exceptional scientists. The company's clear purpose is to develop therapies designed for accuracy, improving patient outcomes and setting new standards in the field of biotechnology. We invite the manager of COMED Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further highlight your groundbreaking work.